Magle Chemoswed Holding AB (publ) (FRA:52X)

Germany flag Germany · Delayed Price · Currency is EUR
0.3960
+0.0060 (1.54%)
Last updated: Apr 23, 2026, 9:55 AM CET
Market Cap8.96M -84.5%
Revenue (ttm)26.57M +19.5%
Net Income-14.77M
EPS-0.72
Shares Outn/a
PE Ration/a
Forward PE3.29
Dividendn/a
Ex-Dividend Daten/a
Volume1,066
Average Volumen/a
Open0.3960
Previous Close0.3900
Day's Range0.3960 - 0.3960
52-Week Range0.3240 - 2.4400
Betan/a
RSI29.48
Earnings DateMay 15, 2026

About FRA:52X

Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease. The company also offers EmboCept S, a microsphere-based medical dev... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1944
Employees 140
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 52X

Financial Performance

Financial numbers in SEK Financial Statements